您当前位置：首页 > 国际期刊-Pharmacology Research & Perspectives期刊投稿发表详细信息

Pharmacology Research & Perspectives Q2

期刊收录：
SCIE
Scopus
DOAJ

基本信息

期刊ISSN：
2052-1707
期刊简拼：
PHARMACOL RES PERSPE
年发文章数：
104
E-ISSN：
Gold OA文章占比
67.87%
研究文章占比：
90.38%
是否OA：
Yes
Jcr分区：
Q2
中科院分区：
4区

出版信息

出版商：
Wiley-Blackwell
涉及研究方向：
Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
出版国家：
ENGLAND
出版语言：
English
出版周期：
出版年份：

2023-2024最新影响因子:2.9
自引率:0.00%
五年影响因子:2.9
JCI期刊引文指标:0.73
h-index:暂无h-index数据
CiteScore:5.30

期刊关键词

2区 SCIE Scopus DOAJ 医学 4区 PHARMACOLOGY & PHARMACY 药学

期刊简介

PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS

《Pharmacology Research & Perspectives》期刊已被查看：次
期刊简写：PHARMACOL RES PERSPE

此期刊被最新的JCR期刊SCIE收录